RSCF — Reflect Scientific Income Statement
0.000.00%
- $3.28m
- $2.25m
- $1.08m
- 76
- 57
- 34
- 56
Annual income statement for Reflect Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.61 | 2.79 | 2.81 | 2.04 | 1.08 |
Cost of Revenue | |||||
Gross Profit | 0.992 | 1.72 | 1.93 | 1.22 | 0.596 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1.8 | 2.14 | 1.88 | 1.95 | 1.55 |
Operating Profit | -0.195 | 0.651 | 0.939 | 0.09 | -0.467 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.196 | 0.66 | 0.939 | 0.09 | -0.459 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.196 | 0.66 | 0.939 | 0.089 | -0.459 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.196 | 0.66 | 0.939 | 0.089 | -0.459 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.196 | 0.66 | 0.939 | 0.089 | -0.459 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.002 | 0.008 | 0.01 | 0.001 | -0.005 |